Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance

Oruka Therapeutics Inc. Common StockTrade
Vanguard Global ex-US Real Estate Index Fd ETFTrade

Price performance (Past 24H)

Key statistics

Oruka Therapeutics Inc. Common Stock vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $42 (market cap $3.80B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Vanguard Global ex-US Real Estate Index Fd ETF for 96 Days on average.

ORKAVNQI
Market Cap
$5.18B$3.80B
Volume
490,798274,816
Sector
Health—
52-Week High
$113.08$50.76
52-Week Low
$26.19$41.81
Typical Hold Time
0 Days96 Days
Enterprise Value
$4.31B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Vanguard Global ex-US Real Estate Index Fd ETF

VNQI trades at $42.04, up 0.14% on the day, but technical indicators signal a bearish trend with moving averages and overall signals pointing lower. The ETF focuses on international real estate outside the U.S., offering diversification across more than 30 countries and a competitive expense ratio of 0.12%. Recent news highlights a significant drop in short interest in September 2026, suggesting reduced bearish speculation, while comparisons with peers emphasize its higher dividend yield.

The outlook remains cautious due to global real estate market volatility and bearish technicals, though reduced short interest and international exposure present opportunities for yield-seeking investors. Risks include currency fluctuations and economic downturns in foreign markets, requiring careful monitoring of macroeconomic trends for potential recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORKA
100% Buy0% Sell
Avg holding period · 0 Days
VNQI

No sentiment data available yet.

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →

About Vanguard Global ex-US Real Estate Index Fd ETF

The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).

Read more on VNQI →